Seeing Is Believing
Ratings and price targets from Canaccord analysts, and how many of their targets were reached. Latest call 12 November 2026.
934 Buy, 199 Hold and 0 Sell from 31 October 2025 to 30 October 2026. 405 target raises and 346 cuts.
Targets set above the share price from 2008 to October 2025. Across all firms the figure is 59.2%. How we measure.
Share of the 199 stocks with a sector on AnaChart.
| Analyst | Ratings, 12 mo | Price targets | Stocks | Avg upside | Targets met | Last call |
|---|---|---|---|---|---|---|
| Austin Moeller | Buy 86%Hold 14%Sell 0% | 479 | 56 | +114.3% | 12 Nov 2026 | |
| Joseph Vafi | Buy 92%Hold 8%Sell 0% | 879 | 81 | +45.1% | 12 Nov 2026 | |
| George Gianarikas | Buy 87%Hold 13%Sell 0% | 481 | 53 | +66% | 11 Nov 2026 | |
| Susan Anderson | Buy 71%Hold 29%Sell 0% | 788 | 83 | +26% | 11 Nov 2026 | |
| Kyle Mikson | Buy 71%Hold 29%Sell 0% | 448 | 44 | +43.1% | 11 Nov 2026 | |
| Kingsley Crane | Buy 79%Hold 21%Sell 0% | 376 | 47 | +27.5% | 11 Nov 2026 | |
| William Plovanic | Buy 93%Hold 7%Sell 0% | 634 | 56 | +47.9% | 11 Nov 2026 | |
| David Hynes | Buy 80%Hold 20%Sell 0% | 956 | 87 | +41.7% | 10 Nov 2026 | |
| Edward Nash | Buy 93%Hold 7%Sell 0% | 415 | 77 | +107.2% | 9 Nov 2026 | |
| Jason Mills | Buy 75%Hold 25%Sell 0% | 245 | 25 | +23.9% | 9 Nov 2026 | |
| Sumant Kulkarni | Buy 98%Hold 2%Sell 0% | 413 | 48 | +162.4% | 6 Nov 2026 | |
| Luke Hannan | Buy 100%Hold 0%Sell 0% | 21 | 5 | +49.5% | 6 Nov 2026 | |
| Brian McNamara | Buy 75%Hold 25%Sell 0% | 485 | 51 | +39.7% | 6 Nov 2026 | |
| Luke Morison | Buy 50%Hold 50%Sell 0% | 13 | 4 | +31.3% | 6 Nov 2026 | |
| Richard Close | Buy 84%Hold 16%Sell 0% | 721 | 73 | +34.3% | 6 Nov 2026 | |
| Caitlin Cronin | Buy 79%Hold 21%Sell 0% | 126 | 23 | +41% | 6 Nov 2026 | |
| Gary Nachman | Buy 85%Hold 15%Sell 0% | 46 | 9 | +74.6% | 6 Nov 2026 | |
| Michael Graham | Buy 100%Hold 0%Sell 0% | 474 | 50 | +63.9% | 3 Nov 2026 | |
| Whitney Ijem | Buy 86%Hold 14%Sell 0% | 310 | 42 | +227.5% | 2 Nov 2026 | |
| John Newman | Buy 97%Hold 3%Sell 0% | 310 | 61 | +120.2% | 2 Nov 2026 | |
| Kyle Rose | Buy 86%Hold 14%Sell 0% | 244 | 32 | +147.8% | 30 Oct 2026 | |
| John Young | Buy 75%Hold 25%Sell 0% | 52 | 5 | +105.6% | 9 Oct 2026 | |
| Amit Dayal | n/a | 13 | 1 | +41.2% | 2 Oct 2026 | |
| Maria Ripps | Buy 72%Hold 28%Sell 0% | 695 | 61 | +53.1% | 25 Sep 2026 | |
| Caitlin Roberts | Buy 83%Hold 17%Sell 0% | 9 | 3 | +25.2% | 10 Aug 2026 | |
| Caitlin Burrows | Buy 100%Hold 0%Sell 0% | 5 | 1 | +26.7% | 10 Aug 2026 | |
| T. Walkley | Buy 50%Hold 50%Sell 0% | 488 | 40 | +156.9% | 26 Jun 2026 | |
| Matthew Weber | Buy 100%Hold 0%Sell 0% | 3 | 1 | n/a | Under 5 targets | 21 May 2026 |
| Carey Macrury | Buy 83%Hold 17%Sell 0% | 70 | 24 | +55.6% | 19 May 2026 | |
| Jason Tilchen | Buy 84%Hold 16%Sell 0% | 101 | 17 | +61.2% | 14 May 2026 | |
| Robert Young | Buy 67%Hold 33%Sell 0% | 49 | 7 | +32.2% | 14 May 2026 | |
| Jon Young | Buy 75%Hold 25%Sell 0% | 39 | 4 | +113.7% | 14 May 2026 | |
| Bill Maughan | Buy 100%Hold 0%Sell 0% | 95 | 23 | +86.2% | 6 May 2026 | |
| Dalton Baretto | Buy 67%Hold 33%Sell 0% | 85 | 18 | +56.4% | 29 Apr 2026 | |
| Tim Huff | Buy 100%Hold 0%Sell 0% | 6 | 2 | +26.6% | 24 Apr 2026 | |
| Richard Davis | Buy 100%Hold 0%Sell 0% | 380 | 47 | +20% | 23 Apr 2026 | |
| Bill Selesky | n/a | 8 | 2 | +16.7% | 17 Mar 2026 | |
| Matthew Lee | Buy 67%Hold 33%Sell 0% | 15 | 7 | +39.6% | 12 Mar 2026 | |
| Katie Lachapelle | Buy 0%Hold 100%Sell 0% | 23 | 12 | +30% | 16 Jan 2026 |
Analysts with a call in the past 12 months, latest first. Price targets, upside and targets met are each analyst's full Canaccord record, as on AnaChart stock pages, shown from 5 targets. Updated daily.
| Date | Stock | Analyst | Action | Price target | Rating |
|---|---|---|---|---|---|
| 12 Nov 2026 | MRCY | Austin Moeller | Raised | $128 → $129 | Buy |
| 12 Nov 2026 | HIVE | Joseph Vafi | Cut | $10 → $6 | Buy |
| 11 Nov 2026 | AMRC | George Gianarikas | Cut | $62 → $61 | Buy |
| 11 Nov 2026 | LTRX | Austin Moeller | Cut | $11 → $10.50 | Buy |
| 11 Nov 2026 | SBH | Susan Anderson | Raised | $20 → $25 | Buy |
| 11 Nov 2026 | XGN | Kyle Mikson | Cut | $11 → $9 | Buy |
| 11 Nov 2026 | ACHR | Austin Moeller | Cut | $12 → $9.50 | Buy |
| 11 Nov 2026 | QBTS | Kingsley Crane | Cut | $41 → $31 | Buy |
| 11 Nov 2026 | BODI | Susan Anderson | Cut | $19 → $12 | Buy |
| 11 Nov 2026 | TLSI | William Plovanic | Cut | $7 → $4 | Buy |
| 10 Nov 2026 | MNDY | David Hynes | Cut | $115 → $90 | Buy |
| 10 Nov 2026 | RPAY | Joseph Vafi | Cut | $8 → $7 | Buy |
| 9 Nov 2026 | CLDX | Edward Nash | Raised | $60 → $68 | Buy |
| 9 Nov 2026 | TMDX | Jason Mills | Raised | $95 → $120 | Buy |
| 9 Nov 2026 | MP | George Gianarikas | Cut | $82 → $70 | Buy |
| 9 Nov 2026 | OKLO | George Gianarikas | Cut | $100 → $66 | Buy |
| 9 Nov 2026 | VEEV | David Hynes | Raised | $260 → $315 | Hold |
| 6 Nov 2026 | ACAD | Sumant Kulkarni | Raised | $36 → $38 | Buy |
| 6 Nov 2026 | FROG | Kingsley Crane | Raised | $95 → $110 | Buy |
| 6 Nov 2026 | GIL | Luke Hannan | Cut | $43 → $41 | Buy |
| 6 Nov 2026 | IPAR | Susan Anderson | Raised | $151 → $154 | Buy |
| 6 Nov 2026 | MIDD | Brian McNamara | Maintained | $160 | Buy |
| 6 Nov 2026 | NSIT | Luke Morison | Raised | $75 → $175 | Hold |
| 6 Nov 2026 | PBH | Susan Anderson | Cut | $72 → $70 | Buy |
| 6 Nov 2026 | PRVA | Richard Close | Cut | $34 → $33 | Buy |
The most recent target from each analyst on each stock. Updated daily.
Which targets were reached, how fast, and each analyst's Performance Score on every stock they cover.
GuggenheimKeyBankBernsteinOppenheimerJMP
Canaccord analysts issued 1,133 ratings from 31 October 2025 to 30 October 2026: 934 Buy, 199 Hold and 0 Sell, on 395 stocks.
55.3% of the 6,589 targets its analysts set above the share price from 2008 to October 2025 were reached within 12 months. For those reached, the median wait was 84 days.
By price targets in the past 12 months: Brian McNamara (95), Kyle Mikson (90), Joseph Vafi (88).
Healthcare leads with 46% of the stocks it rated in the past 12 months.
Source: AnaChart records of analyst ratings and price targets. 12-month figures run from 31 October 2025 to 30 October 2026. Analysts and latest calls update daily. AnaChart publishes data about analysts' past calls. It is not investment advice.